ImmunXperts

Foundation date

15/05/2014

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

ImmunXperts offers a wide range of in silico and in vitro assays to companies developing new drugs. The purpose of these tests is to help our partners select the best and less risky drug candidates before further development into the clinical phases. We want to be a trusted partner for our clients by thinking and working together; acting as their mobile development team in the areas where they need us.

Upcoming events

Latest news

  • Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®

    Monday August 8th 2022

  • S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities

    Tuesday August 2nd 2022

  • Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial

    Monday August 1st 2022